PON2: A Promising Biomarker and Cancer Therapy Target
Recent advancements in cancer research have illuminated the potential roles of various biomarkers in the diagnosis and treatment of malignancies. ...
Tag: cancer treatment resistance mechanisms
NASP Controls Histone Turnover Behind PARP Resistance
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
Small Nucleolar RNAs Shape Thyroid Tumor Immunity
In the relentless pursuit to decode the molecular underpinnings of cancer, the small nucleolar RNAs (snoRNAs) have emerged as compelling ...
April 17, 2025: Key Research Breakthroughs from MD Anderson Unveiled
At the forefront of oncology research, the University of Texas MD Anderson Cancer Center has unveiled a series of groundbreaking ...
MD Anderson Unveils Key Research Breakthroughs: Highlights from March 12, 2025
In recent advances within the realm of cancer research, the University of Texas MD Anderson Cancer Center has showcased multiple ...
Emerging Genetic Mutation Associated with Drug Resistance in Non-Small Cell Lung Cancer Patients
A recent publication details a compelling case study revolving around a patient diagnosed with stage IV non-small cell lung cancer ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!